Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 5/20 | 0.34 |
| ▸ | SAT1 | P21673 | 3/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17288881 | 0.94 | CYP2C19 (0.43) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL4855330 | 0.88 | TDP1 (0.35) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL16506744 | 0.86 | PAOX (0.46) | TSHRPAOXTDP1HDAC1HDAC2 | |
| Diethylamine SCHEMBL21409732 | 0.84 | CES1 (0.39) | CYP2C19MEN1KMT2ACYP1A2TSHR | |
| SCHEMBL303227 | 0.82 | CYP2C19 (0.42) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL3927721 | 0.81 | — | — | |
| Diethylamine SCHEMBL6905146 | 0.79 | CTSD (0.38) | TSHRTDP1HDAC1HDAC2 | |
| SCHEMBL4449313 | 0.79 | TDP1 (0.35) | TDP1 | |
| SCHEMBL19215554 | 0.79 | — | — | |
| SCHEMBL31281219 | 0.78 | HDAC1 (0.41) | TSHRPAOXHDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0118327-B1 | CATIONIC LATICES FROM CONJUGATED DIENES | RHONE-POULENC CHIMIE (FR) | 1987-04-22 | — | — | EP | claimed |
| US-10772822-B2 | Molecularly imprinted polymers and their use as antidandruff agents | L'OREAL (FR) | 2020-09-15 | — | — | US | disclosed |
| EP-2938641-B1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | ORÉAL L (FR) | 2016-08-24 | — | — | EP | disclosed |
| US-20150342859-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | L'OREAL (FR) | 2015-12-03 | — | — | US | disclosed |
| EP-2938641-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | L'Oréal (FR) | 2015-11-04 | — | — | EP | disclosed |
| WO-2014102206-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | L'OREAL (FR) | 2014-07-03 | — | — | WO | disclosed |
| US-7442244-B2 | Water-base ink composition | SEIKO EPSON CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| EP-1688465-A1 | WATER-BASED INK COMPOSITION AND METHOD OF INK-JET RECORDING WITH THE SAME | SEIKO EPSON CORPORATION (JP) | 2006-08-09 | — | — | EP | disclosed |
| US-20050235870-A1 | 2-ethyl-1,3-hexanediol, acetylene glycol surfactant and/or penetrating organic solvent, and humectant; ink jet printing; highly stably ejected and evenly printed on recording media; clogged nozzle problem prevented | SEIKO EPSON CORPORATION | 2005-10-27 | — | — | US | disclosed |
| US-6877851-B2 | Ink set for ink jet recording, ink jet recording process, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2005-04-12 | — | — | US | disclosed |
| EP-0828763-A1 | POLYMER AND SURFACTANT MIXTURES, PROCESS FOR THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-03-18 | — | — | EP | disclosed |
| WO-1997009359-A1 | POWDERY POROUS POLYMERS CONTAINING N-VINYLIMIDAZOL UNITS, PROCESS FOR THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-13 | — | — | WO | disclosed |
| WO-1996037524-A1 | POLYMER AND SURFACTANT MIXTURES, PROCESS FOR THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-28 | — | — | WO | disclosed |
| EP-0605567-A4 | WATER-SOLUBLE FORMULATION FOR MASKING AND THE LIKE, AND METHOD UTILIZING THE SAME. | DYMAX CORP (US) | 1995-08-30 | — | — | EP | disclosed |
| EP-0605567-A1 | WATER-SOLUBLE FORMULATION FOR MASKING AND THE LIKE, AND METHOD UTILIZING THE SAME | DYMAX CORPORATION (US) | 1994-07-13 | — | — | EP | disclosed |
| WO-1993005889-A1 | WATER-SOLUBLE FORMULATION FOR MASKING AND THE LIKE, AND METHOD UTILIZING THE SAME | DYMAX CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
| EP-0331528-A1 | Antimicrobial ethylene copolymers and compositions thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-09-06 | — | — | EP | disclosed |
| EP-0290205-A1 | Electrical storage accumulators containing electrolyte retention means | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-09 | — | — | EP | disclosed |
| EP-0289330-A2 | Thermoplastic spun conjugate fibers and nonwoven molding thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-02 | — | — | EP | disclosed |
| US-4000218-A | PROCESS FOR PREPARING PARTICULATE POLYURETHANE POLYMERS AND THE POLYMERS DERIVED THEREFROM | UNION CARBIDE CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10772822-B2 | Molecularly imprinted polymers and their use as antidandruff agents | DNMT1, POLR1C, ETF1 | CYP2C19 177/4885MEN1 599/4885GLA 4396/4885 |
| US-20150342859-A1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | DNMT1, POLR1C, ETF1 | CYP2C19 177/4885MEN1 599/4885GLA 4396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.